Payer Partnerships Position ETS as a strategic partner to payers, reinsurers, and stop loss carriers for managing the costs of high cost, rare and complex therapies. Highlight LifeTrac’s transplant and provider network expertise alongside ETS focus on cell and gene therapies to enable risk sharing and negotiated cost containment agreements. Leverage the COEUS partnership to widen market access and accelerate collaborations with payers.

Analytics Enablement Leverage the existing tech stack to deliver data driven cost containment offerings with scalable dashboards and ROI analyses that track spend, outcomes, and contract performance for high cost therapies. Use analytics and customer relationship management capabilities to accelerate client onboarding, renewals, and performance visibility for payers.

Therapy Portfolio Broaden the service portfolio to include bone marrow and solid organ transplants along with gene therapies, aligning with ETS strengths to address high cost therapy scenarios. This expansion can strengthen provider relationships and improve contract leverage with payers.

Strategic Alliances Expand strategic alliances by deepening existing collaborations and pursuing new partnerships with value based care, risk management, and contracting experts. Co sell with complementary services to reach more payers, reinsurers, and self funded employers and improve channel reach.

Rare Focus Position as a niche leader for rare and complex therapies with cost containment and risk management solutions, aligning with market trends toward outcomes based contracts and innovative payer arrangements to differentiate from broader health IT competitors.